Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolff

Showing results (961-970 of 973) with videos related to

Pageof 98
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2017
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyMargaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelinesMargaret A Tempero, Mokenge P Malafa, Stephen W Behrman, et al.
JNCI Cancer Spectrum|May 11, 2024
Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volumeEnoch Chang, Franklin C L Wong, Beth A Chasen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2021
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMargaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in OncologyE Gabriela Chiorean, Marco Del Chiaro, Margaret A Tempero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal AdenocarcinomaEugene J Koay, Yeonju Lee, Vittorio Cristini, et al.
Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
Nature Communications|July 9, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinomaJacob E Till, Lee McDaniel, Changgee Chang, et al.
Plos One|June 14, 2022
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatmentNina N Harke, Christian Wagner, Robert M Hermann, et al.
Applied Optics|May 11, 2010
Research on nonlinear optical materials: an assessmentD H Auston, A A Ballman, P Bhattacharya, et al.
Pageof 98

Showing results (961-970 of 973) with videos related to

Sort By:
Pageof 98
Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2017
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyMargaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelinesMargaret A Tempero, Mokenge P Malafa, Stephen W Behrman, et al.
JNCI Cancer Spectrum|May 11, 2024
Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volumeEnoch Chang, Franklin C L Wong, Beth A Chasen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2021
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMargaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in OncologyE Gabriela Chiorean, Marco Del Chiaro, Margaret A Tempero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal AdenocarcinomaEugene J Koay, Yeonju Lee, Vittorio Cristini, et al.
Nature Medicine|June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trialLacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
Nature Communications|July 9, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinomaJacob E Till, Lee McDaniel, Changgee Chang, et al.
Plos One|June 14, 2022
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatmentNina N Harke, Christian Wagner, Robert M Hermann, et al.
Applied Optics|May 11, 2010
Research on nonlinear optical materials: an assessmentD H Auston, A A Ballman, P Bhattacharya, et al.
Pageof 98